24.04.2023 - LA JOLLA, CA, April 24, 2023 (GLOBE NEWSWIRE) - GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, ... Seite 1